Chronic obstructive pulmonary disease (Japanese Version)

WW Labaki, SR Rosenberg - Annals of internal medicine, 2020‏ - acpjournals.org
Disclosures: Dr. Labaki, ACP Contributing Author, reports nonfinancial support from
Pulmonx and personal fees from Konica Minolta outside the submitted work. Dr. Rosenberg …

The remarkable history of pneumococcal vaccination: an ongoing challenge

DM Musher, R Anderson, C Feldman - Pneumonia, 2022‏ - Springer
Although it varies with age and geographical distribution, the global burden of infection with
Streptococcus pneumoniae (pneumococcus) remains considerable. The elderly, and …

[HTML][HTML] Pneumococcal vaccine for adults aged≥ 19 years: recommendations of the Advisory Committee on Immunization Practices, United States, 2023

M Kobayashi - MMWR. Recommendations and reports, 2023‏ - cdc.gov
This report compiles and summarizes all published recommendations from CDC's Advisory
Committee on Immunization Practices (ACIP) for use of pneumococcal vaccines in adults …

[HTML][HTML] Surveillance of vaccination coverage among adult populations—United States, 2018

PJ Lu - MMWR. Surveillance Summaries, 2021‏ - cdc.gov
Abstract Problem/Condition: Adults are at risk for illness, hospitalization, disability and, in
some cases, death from vaccine-preventable diseases, particularly influenza and …

[HTML][HTML] Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among US adults: updated recommendations of the …

M Kobayashi - MMWR. Morbidity and mortality weekly report, 2022‏ - cdc.gov
On October 20, 2021, the Advisory Committee on Immunization Practices recommended 15-
valent PCV (PCV15) or 20-valent PCV (PCV20) for PCV–naïve adults who are either aged≥ …

Pivotal phase 3 randomized clinical trial of the safety, tolerability, and immunogenicity of 20-valent pneumococcal conjugate vaccine in adults aged≥ 18 years

B Essink, C Sabharwal, K Cannon… - Clinical infectious …, 2022‏ - academic.oup.com
Abstract Background Pneumococcal conjugate vaccines (PCVs) have significantly reduced
pneumococcal disease, but disease from non-PCV serotypes remains. The safety …

13. Children and Adolescents: Standards of Medical Care in Diabetes—2021

American Diabetes Association - Diabetes care, 2021‏ - diabetesjournals.org
The American Diabetes Association (ADA)“Standards of Medical Care in Diabetes” includes
the ADA's current clinical practice recommendations and is intended to provide the …

When to update COVID-19 vaccine composition

R Grant, JA Sacks, P Abraham, S Chunsuttiwat… - Nature Medicine, 2023‏ - nature.com
When to update COVID-19 vaccine composition | Nature Medicine Skip to main content Thank
you for visiting nature.com. You are using a browser version with limited support for CSS. To …

Safety, tolerability, and immunogenicity of a 20-valent pneumococcal conjugate vaccine (PCV20) in adults 60 to 64 years of age

D Hurley, C Griffin, M Young Jr, DA Scott… - Clinical Infectious …, 2021‏ - academic.oup.com
Abstract Background Pneumococcal conjugate vaccines (PCVs) have significantly
decreased pneumococcal disease worldwide; however, expanding serotype coverage may …

14. Children and Adolescents: Standards of Medical Care in Diabetes—2022

American Diabetes Association Professional … - Diabetes …, 2022‏ - diabetesjournals.org
The American Diabetes Association (ADA)“Standards of Medical Care in Diabetes” includes
the ADA's current clinical practice recommendations and is intended to provide the …